Literature DB >> 1155551

Blindness from glaucoma.

R Hiller, H A Kahn.   

Abstract

We observed an overall ratio of 8:1 for nonwhite to white primary glaucoma blindness. Our fragmentary evidence suggested that the ratio of underlying disease, that is, nonblinding glaucoma or intraocular pressure differentials, may be closer to 2:1 than 8:1 as between nonwhites and whites. The remaining four fold differential can be explained by a combination of the following: more complete reporting for nonwhites, reporting for medical care later in the disease than whites, and poorer response to treatment for nonwhites compared to whites. The trend of new blindness from glaucoma for recent years was stationary in the United States, England, and Wales.

Entities:  

Mesh:

Year:  1975        PMID: 1155551     DOI: 10.1016/0002-9394(75)90870-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  20 in total

1.  African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry differences in visual function in healthy eyes.

Authors:  Lyne Racette; Jeffrey M Liebmann; Christopher A Girkin; Linda M Zangwill; Sonia Jain; Lida M Becerra; Felipe A Medeiros; Christopher Bowd; Robert N Weinreb; Catherine Boden; Pamela A Sample
Journal:  Arch Ophthalmol       Date:  2010-05

2.  Glaucoma screening: too little, too late?

Authors:  A Sommer
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

Review 3.  Glaucoma blindness in African Americans: have 55 years of therapies, technologies, and talent altered blindness rates?

Authors:  J C Merritt
Journal:  J Natl Med Assoc       Date:  1996-12       Impact factor: 1.798

4.  The African Descent and Glaucoma Evaluation Study (ADAGES) III: Contribution of Genotype to Glaucoma Phenotype in African Americans: Study Design and Baseline Data.

Authors:  Linda M Zangwill; Radha Ayyagari; Jeffrey M Liebmann; Christopher A Girkin; Robert Feldman; Harvey Dubiner; Keri A Dirkes; Matthew Holmann; Eunice Williams-Steppe; Naama Hammel; Luke J Saunders; Suzanne Vega; Kevin Sandow; Kathryn Roll; Rigby Slight; Daniel Auerbach; Brian C Samuels; Joseph F Panarelli; John P Mitchell; Lama A Al-Aswad; Sung Chul Park; Celso Tello; Jeremy Cotliar; Rajendra Bansal; Paul A Sidoti; George A Cioffi; Dana Blumberg; Robert Ritch; Nicholas P Bell; Lauren S Blieden; Garvin Davis; Felipe A Medeiros; Maggie C Y Ng; Swapan K Das; Nicholette D Palmer; Jasmin Divers; Carl D Langefeld; Barry I Freedman; Donald W Bowden; Mark A Christopher; Yii-der I Chen; Xiuqing Guo; Kent D Taylor; Jerome I Rotter; Robert N Weinreb
Journal:  Ophthalmology       Date:  2018-02-01       Impact factor: 12.079

5.  The problem with glaucoma.

Authors:  C L Cowan
Journal:  J Natl Med Assoc       Date:  1988-07       Impact factor: 1.798

6.  Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells.

Authors:  Frank Schuettauf; David Zurakowski; Kristine Quinto; Meghana A Varde; Dorothea Besch; Alan Laties; Ralph Anderson; Rong Wen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

7.  Prevalence of glaucoma in an urban West African population: the Tema Eye Survey.

Authors:  Donald L Budenz; Keith Barton; Julia Whiteside-de Vos; Joyce Schiffman; Jagadeesh Bandi; Winifred Nolan; Leon Herndon; Hanna Kim; Graham Hay-Smith; James M Tielsch
Journal:  JAMA Ophthalmol       Date:  2013-05       Impact factor: 7.389

8.  Glaucoma in the black population: a problem of blindness.

Authors:  K C Greenidge; M Dweck
Journal:  J Natl Med Assoc       Date:  1988-12       Impact factor: 1.798

9.  Glaucomatous blindness in the Negev: a descriptive study of age, sex, and ethnic patterns.

Authors:  R David; Y Dan; D H Stone
Journal:  Br J Ophthalmol       Date:  1983-08       Impact factor: 4.638

10.  Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population.

Authors:  Alexander Pleet; Melanie Sulewski; Rebecca J Salowe; Raymond Fertig; Julia Salinas; Allison Rhodes; William Merritt Iii; Vikas Natesh; Jiayan Huang; Harini V Gudiseva; David W Collins; Venkata Ramana Murthy Chavali; Paul Tapino; Amanda Lehman; Meredith Regina-Gigiliotti; Eydie Miller-Ellis; Prithvi Sankar; Gui-Shuang Ying; Joan M O'Brien
Journal:  Ophthalmic Epidemiol       Date:  2016-06-27       Impact factor: 1.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.